Patent details

93353 Product Name: Cobicistat ou un sel pharmaceutiquement acceptable de celui-ci et atazanavir ou un sel pharmaceutiquement acceptable de celui-ci, en particulier le sulfate d'atazanavir

Basic Information

Publication number:
93353
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP121675912
Legal Status:
Invalid
Application number:
93353
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1025
Marketing Authorization Type:
Marketing Authorization Date:
15/07/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
12/12/2016
First Marketing Authorization date:
15/07/2015
Grant date:
04/04/2017
Activation date:
Publication date:
04/04/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
15/07/2030
SPC Extension Expiration:
15/07/2030
Rejection date:
Withdrawal date:

Owner

From:
12/12/2016
 
 

Name:
GILEAD SCIENCES INC.
Address:
333 Lakeside Drive, Foster City, California 94404, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
12/12/2016
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Vivian Radall, W.
Address:
United States (US)

2

Name:
Desai Manoj, C.
Address:
United States (US)

3

Name:
Xu Lianhong
Address:
United States (US)

4

Name:
Hui Hon, C.
Address:
United States (US)

5

Name:
Hong Allen, Y.
Address:
United States (US)

6

Name:
Liu Hongtao
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC2
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

2

Bulletin Heading:
VRV
Bulletin edition number:
2023/02
Publication date:
08/02/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
04/04/2017 Certificate 1
04/04/2017 Publication 1